View in EDS HTML Full Text PDF Full Text

Clinical trial: seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line Helicobacter pylori eradication.

Saved in:
Bibliographic Details
Title: Clinical trial: seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line Helicobacter pylori eradication.
Authors: Ang, Daphne1 (AUTHOR) ang_daphne@yahoo.com, Koo, Seok Hwee2 (AUTHOR), Chan, Yiong Huak3 (AUTHOR), Tan, Thean Yen4 (AUTHOR), Soon, Gaik Hong2 (AUTHOR), Tan, Chin Kimg1 (AUTHOR), Lin, Kenneth Weicong1 (AUTHOR), Krishnasamy‐Balasubramanian, Jaydeesh‐Khanna1 (AUTHOR), Wong, Yu Jun1 (AUTHOR), Kumar, Rahul1 (AUTHOR), R, Rajesh1 (AUTHOR), Tan, Yiyuan1 (AUTHOR), Ong, Peng‐Lan Jeannie1 (AUTHOR), Tan, Yi‐Lyn Jessica1 (AUTHOR), Li, James Weiquan1 (AUTHOR), Kwek, Andrew Boon‐Eu1 (AUTHOR), Ang, Tiing Leong1 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Aug2022, Vol. 56 Issue 3, p436-449. 14p. 1 Diagram, 7 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.17070